Paul G. Harch, MD and Teri Small

As hyperbaric oxygen therapy (HBOT) moves closer to a standard of care for many deemed ‘hopeless’ diseases it still remains a controversial and misunderstood treatment. Currently there are thirteen medical conditions approved for treatment with HBOT. But over twenty-two years of experience has shown Dr. Paul Harch astounding medical benefits when applied to diseases like Cerebral Palsy Autism, Stroke, Traumatic Brain Injury, and many others. This interview explores the science behind these applications.

Teri Small, from AutismOne Radio, and Dr. Harch talk about HBOT defined as a pharmaceutical and its pharmacologic effects in the application of HBOT to neurology, including autism.